Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Clinical Trial, Phase II

Research Support, Non-U.S. Gov't

Clinical Trial

Multicenter Study

Randomized Controlled Trial

Comparative Study

Review

Clinical Trial, Phase I

Case Reports

Clinical Trial, Phase III

Meta-Analysis

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase IV

Observational Study

English Abstract

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2022

2020

2019

2017

2016

2014

2013

2009

2007

2006

2005

2004

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Asthenia""[mesh_terms]

30 Results

Searching titles within these results

Acute and subacute weakness.

Marguerite Hill

Clinical medicine (London, England) 2004;4(2):105-7

Free Full Text

Abstract

Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX).

Pierre Martin, Damien Botsen, Mathias Brugel, Eric Bertin, Claire Carlier, Rachid Mahmoudi, Florian Slimano, Marine Perrier, Olivier Bouché

Nutrients 2022;14(21):4448

Free Full Text

Abstract

[Not Available].

A-C Magain, T Richard, B De Becker, S Rorive, A Benahmed, M Vanhaeverbeek

Revue medicale de Bruxelles 2016;37(1):26-34

Full Text

Abstract

Evaluation of the patient with muscle weakness.

Aaron Saguil

American family physician 2005;71(7):1327-36

Free Full Text

Abstract

Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant.

Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann, Antonella Semeraro, Simona Borsari, Chiara Sardella, Fulvia Baldinotti, Maria Adelaide Caligo, Glenville Jones, Claudio Marcocci, Filomena Cetani

The Journal of clinical endocrinology and metabolism 2022;107(8):e3159-e3166

Full Text

Abstract

Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.

Herbert R Henney, Jaymin Shah

Clinical therapeutics 2007;29(4):661-9

Full Text

Abstract

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial.

Philippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, Gilles Pelletier, Jean-Pierre Bronowicki, Yann Touchefeu, Georges Pageaux, René Gerolami, François Habersetzer, Eric Nguyen-Khac, Andrea Casadei-Gardini, Ivan Borbath, Albert Tran, Henning Wege, Amr Shafik Saad, Massimo Colombo, Armand Abergel, Carine Richou, Imam Waked, Nelson S Yee, Audrey Molé, Pierre Attali, Julie Le Boulicaut, Bérangère Vasseur

The lancet. Gastroenterology & hepatology 2020;4(6):454-465

Free Full Text

Abstract

The role of rehabilitation medicine and palliative care in the treatment of patients with end-stage disease.

Ellen Olson, Adrian Cristian

Physical medicine and rehabilitation clinics of North America 2005;16(1):285-305, xi

Full Text

Abstract

Salvage treatment with docetaxel for recurrent epithelial ovarian cancer.

Yoshimitsu Niwa, Toru Nakanishi, Kazuo Kuzuya, Akihiro Nawa, Shigehiko Mizutani

International journal of clinical oncology 2004;8(6):343-7

Full Text

Abstract

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.

J Tabernero, M A Climent, A Lluch, J Albanell, J B Vermorken, A Barnadas, A Antón, C Laurent, J I Mayordomo, N Estaun, I Losa, V Guillem, J Garcia-Conde, J L Tisaire, J Baselga

Annals of oncology : official journal of the European Society for Medical Oncology 2005;15(9):1358-65

Free Full Text

Abstract

Efficacy and safety of haemodialysis treatment with the Hemocontrol biofeedback system: a prospective medium-term study.

C Basile, R Giordano, L Vernaglione, A Montanaro, P De Maio, F De Padova, A L Marangi, L Di Marco, D Santese, A Semeraro, V A Ligorio

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(2):328-34

Full Text

Abstract

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).

R Gervais, A Ducolone, J-L Breton, D Braun, B Lebeau, F Vaylet, D Debieuvre, J-L Pujol, J Tredaniel, P Clouet, E Quoix

Annals of oncology : official journal of the European Society for Medical Oncology 2005;16(1):90-6

Free Full Text

Abstract

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.

W M Stadler, N J Vogelzang, R Amato, J Sosman, D Taber, D Liebowitz, E E Vokes

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):371-5

Full Text

Abstract

No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.

K Schaffler, O T Wolf, M Burkart

Pharmacopsychiatry 2014;46(5):181-90

Full Text

Abstract

Raltitrexed-based chemotherapy for advanced colorectal cancer.

Y Liu, W Wu, W Hong, X Sun, J Wu, Q Huang

Clinics and research in hepatology and gastroenterology 2014;38(2):219-25

Full Text

Abstract

Results: 1 – 15 / 30

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Asthenia""[mesh_terms]

Acute and subacute weakness.

Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX).

[Not Available].

Evaluation of the patient with muscle weakness.

Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant.

Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial.

The role of rehabilitation medicine and palliative care in the treatment of patients with end-stage disease.

Salvage treatment with docetaxel for recurrent epithelial ovarian cancer.

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.

Efficacy and safety of haemodialysis treatment with the Hemocontrol biofeedback system: a prospective medium-term study.

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.

No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.

Raltitrexed-based chemotherapy for advanced colorectal cancer.

Results for
""Asthenia""[mesh_terms]